# The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

> **NCT06750159** · — · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **OTHER:** No intervention (observational study)

## Key facts

- **NCT ID:** NCT06750159
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06750159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06750159, "The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06750159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*